Analyst Activity – Cantor Fitzgerald Lowers Its Price Target On NYSE:AGN – Allergan (NYSE:AGN) to $180.00

0

Analyst Ratings For NYSE:AGN – Allergan (NYSE:AGN)

Today, Cantor Fitzgerald lowered its price target on NYSE:AGN – Allergan (NYSE:AGN) to $180.00 per share.

Some recent analyst ratings include

  • 5/1/2018-Wells Fargo Reiterated Rating of Outperform .
  • 4/24/2018-Citigroup Reiterated Rating of Buy .
  • 4/23/2018-Evercore ISI initiated coverage with a Outperform rating.

Dividend information for NYSE:AGN – Allergan (NYSE:AGN)

NYSE:AGN – Allergan (NYSE:AGN) pays an annual dividend of $2.88 with a yield of 1.89% and an average dividend growth of 141.00% based on a 3 Year Average..

Dividend History for NYSE:AGN – Allergan (NYSE:AGN)

  • On 2/9/2018 NYSE:AGN – Allergan announced a quarterly dividend of $0.72 1.71% with an ex dividend date of 2/27/2018 which will be payable on 3/28/2018.
  • On 10/27/2017 NYSE:AGN – Allergan announced a quarterly dividend of $0.70 1.58% with an ex dividend date of 11/16/2017 which will be payable on 12/15/2017.
  • On 8/2/2017 NYSE:AGN – Allergan announced a Quarterly dividend of $0.70 1.12% with an ex dividend date of 8/16/2017 which will be payable on 9/15/2017.
  • On 5/5/2017 NYSE:AGN – Allergan announced a quarterly dividend of $0.70 0.01% with an ex dividend date of 5/16/2017 which will be payable on 6/15/2017.
  • On 11/2/2016 NYSE:AGN – Allergan announced a quarterly dividend of $0.70 with an ex dividend date of 2/24/2017 which will be payable on 3/28/2017.
  • On 2/4/2015 NYSE:AGN – Allergan announced a quarterly dividend of $0.05 0.09% with an ex dividend date of 2/5/2015 which will be payable on 3/20/2015.
  • On 10/27/2014 NYSE:AGN – Allergan announced a quarterly dividend of $0.05 with an ex dividend date of which will be payable on 12/11/2014.

Recent Insider Trading Activity For NYSE:AGN – Allergan (NYSE:AGN)
NYSE:AGN – Allergan (NYSE:AGN) has insider ownership of 0.37% and institutional ownership of 78.27%.

  • On 3/15/2018 Maria Teresa Hilado, Insider, bought 895 with an average share price of $167.39 per share and the total transaction amounting to $149,814.05.
  • On 3/8/2018 Brent L. Saunders, CEO, bought 3,300 with an average share price of $152.53 per share and the total transaction amounting to $503,349.00.
  • On 3/8/2018 Matthew M. Walsh, CFO, bought 1,000 with an average share price of $153.96 per share and the total transaction amounting to $153,960.00.
  • On 3/5/2018 Joseph H. Boccuzi, Director, bought 900 with an average share price of $143.42 per share and the total transaction amounting to $129,078.00.
  • On 2/21/2018 Matthew M Walsh, CFO, bought 2,000 with an average share price of $160.94 per share and the total transaction amounting to $321,880.00.
  • On 2/14/2018 William Meury, Insider, sold 58,879 with an average share price of $160.62 per share and the total transaction amounting to $9,457,144.98.
  • On 12/7/2017 Chris W. Bodine, Director, bought 3,030 with an average share price of $164.77 per share and the total transaction amounting to $499,253.10.

Recent Trading Activity for NYSE:AGN – Allergan (NYSE:AGN)
Shares of NYSE:AGN – Allergan closed the previous trading session at 152.36 down -1.27 0.83% with 150.94000244140625 shares trading hands.